Please login to the form below

Not currently logged in
Email:
Password:

Lilly promotes Aarti Shah as chief information officer

She moves up from her role as a global brand development leader

Aarti Shah has been promoted to senior VP and chief information officer at Lilly, moving up from a role as the firm's global brand development leader for immunology.

She joined the pharma firm in 1994 as a senior statistician, subsequently holding a number of technical and administrative leadership positions in the US and abroad.

In that time her roles included serving as vice president for biometrics and advanced analytics and as executive director of global information sciences.

She said: "I want to create an environment in which IT enables and brings innovative solutions to business transformations across Lilly's entire drug development value chain from discovery to commercial. 

“I hope to do this by unleashing the potential of our employees and by building strong internal and external collaborations and thus play a critical role in bringing Lilly's mission to life."

In her new role, she will lead the efforts of a worldwide IT organisation with more than 1,300 employees and report to Derica Rice, Lilly's executive vice president of Global Services and chief financial officer. 

Rice said: "As a visionary and inspirational leader, Aarti has a proven track record of building strong, flexible and sustainable organisations. She is known for her relentless focus and passion for developing people. And her deep knowledge of drug development will be vital as IT touches every aspect of our business."

23rd June 2016

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aurora Healthcare Communications

We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...

Latest intelligence

digital launch
How can virtual pharma companies de-risk new product launches?
The risks and challenges involved in taking specialty drugs, biopharmaceuticals and drug/device combinations to market...
Not waving but drowning. Reflections on data curation in the age of information overload
...
digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...

Infographics